Evidence map›Paper›PMID 42337179›Full record

ArticleInternational ophthalmology2026

Improvement of pattern electroretinogram parameters following glaucoma surgery.

Emmanuel Bettach, Leandro Oliverio, Kaweh Mansouri, André Mermoud

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Emmanuel BettachSwiss Visio Glaucoma Research Center, Montchoisi Clinic, Lausanne, Switzerland. manou.bettach@gmail.com.
Leandro OliverioSwiss Visio Glaucoma Research Center, Montchoisi Clinic, Lausanne, Switzerland.
Kaweh MansouriSwiss Visio Glaucoma Research Center, Montchoisi Clinic, Lausanne, Switzerland. KMansouri@swissvisio.net.
André MermoudSwiss Visio Glaucoma Research Center, Montchoisi Clinic, Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the dynamics of Pattern Electroretinogram (PERG) parameters following glaucoma surgery in individuals with glaucomatous optic neuropathy.

methodsThe is a single center retrospective study. Preoperative PERG were conducted on moderate and advanced glaucoma patients scheduled for glaucoma surgery. Subsequently, the patients underwent an additional PERG a few months after the procedure. Comparative analysis focused on the PERG parameters (Mag, MagD and MagD/Mag ratio) before and after the glaucoma surgery in eyes achieving successful intraocular pressure (IOP) reduction post-operatively.

resultsThe study enrolled 23 eyes from 21 consecutive patients who underwent successful glaucoma surgery between January 2021 and December 2023, each with both pre and post-operative PERG assessments. Postoperatively, there was a significant improvement of all the PERG parameters (0.97 ± 0.29 to 1.36 ± 0.29 μV, 0.55 ± 0.3 to 0.84 ± 0.42 μV, 0.52 ± 0.2 to 0.68 ± 0.25 for Mag, MagD and MagD/Mag ratio respectively, all p < 0.05). Three patients who had no IOP reduction postoperatively showed no improvement of all PERG parameters following the surgery.

conclusionsGlaucoma surgery, leading to effective IOP reduction, may demonstrate a positive impact on the functional activity of the retinal ganglion cells, as evidenced by the enhancement in PERG parameters post-operatively.

Indexed as

ElectroretinographyGlaucomaIntraocular PressureRetinal Ganglion CellsVisual FieldsAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPostoperative PeriodRetrospective StudiesGlaucomaGlaucoma surgeryIOPPattern electroretinogramRetinal Ganglion Cells

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.